May 8, 2019 Odette Audet

TSO3 Announces the Vote Results from its Annual Meeting of the Shareholders

Quebec City, Canada and Myrtle Beach, United States, May 8, 2019 – TSO3 Inc. (TSX: TOS), (“TSO3” or the “Company”), an innovator in sterilization technology for medical devices in healthcare settings, today announced that the nominees listed in the management proxy circular dated April 4, 2019, were elected as directors of TSO3. In addition, all other proposals submitted by management were approved.Election of Directors Based on the proxies received and the votes on a show of hands, the following individuals were elected as directors of the Company until the next annual shareholders’ meeting. Accordingly, the results are set out below:

 Name  Votes for  % for  Withheld  % withheld
Sara Elford 24,502,253 94.57 1,407,129 5.43
Martin J. Madden 24,219,590 93.48 1,689,792 6.52
Jeffrey Pompeo 21,019,592 81.13 4,889,790 18.87
Jean-Pierre Robert 21,213,336 81.88 4,696,046 18.12
Linda Rosentstock 21,714,350 83.81 4,195,032 16.19
Richard M. Rumble 20,395,438 78.72 5,513,944 21.28
Steve West 21,692,971 83.73 4,216,411 16.27

Other Proposals


 Proposals  Votes for  % for  Withheld  % withheld
Appointment of Independent Auditors 27,794,707 87.17  4,089,764  12.83

Final voting results on all matters voted at the Annual Meeting of Shareholders held on May 7, 2019, will be filed on SEDAR ( under the name TSO3.

About TSO3

Founded in 1998, TSO3‘s activities encompass the sale, production, maintenance, research, development and licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices. The Company designs products for sterile processing areas in the hospital environment that offer an advantageous replacement solution to other low temperature sterilization processes currently used in hospitals. TSO3 also offers services related to the maintenance of sterilization equipment and compatibility testing of medical devices with such processes.

For more information about TSO3, visit the Company’s website at

Back to Posts